CHD2-ACSBG1 Fusion FISH Probe
The CHD2-ACSBG1 Fusion FISH Probe is used to confirm a fusion of the CHD2 and ACSBG1 genes. The fusion of the CHD2 and ACSBG1 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CHD2-ACSBG1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CHD2-ACSBG1-20-AQAQ | 20 (40 μL) | 200 μL |
|
CHD2 Gene Summary
The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Gene Name: Chromodomain Helicase DNA Binding Protein 2
Chromosome: CHR15: 93443550 -93571237
Locus: 15q26.1
ACSBG1 Gene Summary
The protein encoded by this gene possesses long-chain acyl-CoA synthetase activity. It is thought to play a central role in brain very long-chain fatty acids metabolism and myelinogenesis. [provided by RefSeq, Jul 2008]
Gene Name: Acyl-CoA Synthetase Bubblegum Family Member 1
Chromosome: CHR15: 78463186 -78527049
Locus: 15q25.1
Gene Diseases
The CHD2 ACSBG1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|